|
|
|
Insider
Information: |
Lyons Gary A |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
506,803 |
|
Indirect Shares
|
387,931 |
|
|
Direct
Value |
$15,858,872 |
|
|
Indirect Value
|
$44,683,551 |
|
|
Total
Shares |
894,734 |
|
|
Total
Value |
$60,542,423 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-08-13 |
119,047 |
2005-12-19 |
383,573 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2003-11-25 |
0 |
2003-11-25 |
0 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Director |
2020-12-31 |
18,762 |
2009-05-21 |
0 |
Premium* |
|
Poniard Pharmaceuticals |
PARD |
Director |
2011-07-11 |
206,145 |
2010-07-12 |
0 |
Premium* |
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
36,849 |
2016-06-15 |
4,358 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
|
2024-05-08 |
51,000 |
2014-10-08 |
0 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2023-05-26 |
75,000 |
2021-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2003-12-11 |
4 |
S |
$54.90 |
$549,811 |
D/D |
(10,000) |
682,013 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-03-01 |
4 |
A |
$55.15 |
$220,600 |
D/D |
4,000 |
676,013 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-02-03 |
4 |
S |
$56.50 |
$566,204 |
D/D |
(10,000) |
672,013 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-03-01 |
4 |
AS |
$54.09 |
$541,510 |
I/I |
(10,000) |
666,013 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-04-01 |
4 |
AS |
$58.16 |
$581,600 |
I/I |
(10,000) |
656,723 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-05-03 |
4 |
AS |
$62.50 |
$626,250 |
I/I |
(10,000) |
646,723 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-06-01 |
4 |
AS |
$56.04 |
$560,400 |
I/I |
(10,000) |
636,723 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-02-14 |
4 |
A |
$42.78 |
$241,493 |
D/D |
5,645 |
632,368 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-07-01 |
4 |
AS |
$51.00 |
$514,288 |
I/I |
(10,000) |
626,723 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-12-08 |
4 |
A |
$45.87 |
$298,155 |
I/I |
6,500 |
626,723 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-12-08 |
4 |
D |
$45.87 |
$298,155 |
D/D |
(6,500) |
620,223 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-06-15 |
4 |
S |
$39.70 |
$198,500 |
D/D |
(5,000) |
472,852 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-08-18 |
4 |
S |
$46.60 |
$233,779 |
D/D |
(5,000) |
467,852 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-09-06 |
4 |
S |
$48.00 |
$240,000 |
D/D |
(5,000) |
462,852 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-09-07 |
4 |
S |
$50.00 |
$250,000 |
D/D |
(5,000) |
457,852 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-10-27 |
4 |
S |
$51.00 |
$255,000 |
D/D |
(5,000) |
453,106 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-10-28 |
4 |
S |
$52.00 |
$260,000 |
D/D |
(5,000) |
448,106 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-11-02 |
4 |
S |
$55.00 |
$275,047 |
D/D |
(5,000) |
443,106 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2007-04-23 |
4 |
OE |
$7.38 |
$465,296 |
D/D |
63,091 |
439,656 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2007-04-26 |
4/A |
OE |
$7.38 |
$465,296 |
D/D |
63,091 |
439,656 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-11-03 |
4 |
S |
$57.56 |
$287,800 |
D/D |
(5,000) |
438,106 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-11-18 |
4 |
S |
$59.70 |
$298,511 |
D/D |
(5,000) |
433,106 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-11-22 |
4 |
S |
$61.70 |
$308,899 |
D/D |
(5,000) |
428,106 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
officerTitle |
|
2005-12-05 |
4 |
S |
$61.93 |
$309,748 |
D/D |
(5,000) |
423,106 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
officerTitle |
|
2005-12-19 |
4 |
A |
$61.39 |
$346,669 |
I/I |
5,647 |
383,573 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|